{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:52:50Z","timestamp":1790675570983,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["1ZIAHG200318-17"],"award-info":[{"award-number":["1ZIAHG200318-17"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001708","name":"International Foundation for Research in Paraplegia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS100779"],"award-info":[{"award-number":["R01 NS100779"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 CA197561"],"award-info":[{"award-number":["R35 CA197561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ymthe.2020.12.031","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:54:48Z","timestamp":1609455288000},"page":"691-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Yedda","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren K.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy J.","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai M.","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"Vogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Ory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.12.031_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/brain\/39.1-2.74","article-title":"A new familial, infantile form of diffuse brain-sclerosis","volume":"39","author":"Krabbe","year":"1916","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2020.12.031_bib2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jnr.23743","article-title":"Krabbe disease: One Hundred years from the bedside to the bench to the bedside","volume":"94","author":"Wenger","year":"2016","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ymthe.2020.12.031_bib3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1212\/WNL.0000000000004418","article-title":"Developmental outcomes of cord blood transplantation for Krabbe disease: A 15-year study","volume":"89","author":"Wright","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2020.12.031_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/brain\/103.3.695","article-title":"Hereditary leucodystrophy in the mouse: the new mutant twitcher","volume":"103","author":"Duchen","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2020.12.031_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0006-8993(80)90159-6","article-title":"The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease)","volume":"202","author":"Kobayashi","year":"1980","journal-title":"Brain Res."},{"issue":"R1","key":"10.1016\/j.ymthe.2020.12.031_bib6","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1093\/hmg\/ddr112","article-title":"Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?","volume":"20","author":"Hawkins-Salsbury","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.12.031_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.pediatrneurol.2014.08.003","article-title":"Experimental therapies in the murine model of globoid cell leukodystrophy","volume":"51","author":"Li","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymthe.2020.12.031_bib8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/jnr.23822","article-title":"Treatment for Krabbe\u2019s disease: Finding the combination","volume":"94","author":"Mikulka","year":"2016","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ymthe.2020.12.031_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1203\/00006450-200201000-00009","article-title":"Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy","volume":"51","author":"Biswas","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymthe.2020.12.031_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.mt.6300026","article-title":"Central nervous system-directed AAV2\/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy","volume":"15","author":"Lin","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib11","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/mt.2015.145","article-title":"Long-term improvements in lifespan and pathology in CNS and PNS after BMT plus one intravenous injection of AAVrh10-GALC in Twitcher mice","volume":"23","author":"Rafi","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib12","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1093\/hmg\/ddv086","article-title":"Combined gene\/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy","volume":"24","author":"Ricca","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.12.031_bib13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jnr.23882","article-title":"Intrathecal administration of AAV\/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant","volume":"94","author":"Karumuthil-Melethil","year":"2016","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ymthe.2020.12.031_bib14","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1523\/JNEUROSCI.1802-11.2011","article-title":"Bone marrow transplantation augments the effect of brain- and spinal-cord-directed AAV 2\/5 gene therapy by altering inflammation in the murine model of GLD","volume":"31","author":"Reddy","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2020.12.031_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-4159.1984.tb02716.x","article-title":"Inhibition of sphingolipid synthesis by cycloserine in\u00a0vitro and in\u00a0vivo","volume":"42","author":"Sundaram","year":"1984","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2020.12.031_bib16","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1523\/JNEUROSCI.4199-14.2015","article-title":"Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy","volume":"35","author":"Hawkins-Salsbury","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2020.12.031_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ymthe.2005.11.015","article-title":"Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain","volume":"13","author":"Cearley","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib18","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.gt.3301541","article-title":"Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors","volume":"8","author":"Donsante","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","article-title":"AAV vector integration sites in mouse hepatocellular carcinoma","volume":"317","author":"Donsante","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.12.031_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI79213","article-title":"Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy","volume":"125","author":"Chandler","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.12.031_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/mt.2014.240","article-title":"Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates","volume":"23","author":"Walia","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.12.031_bib23","doi-asserted-by":"crossref","first-page":"44311","DOI":"10.1074\/jbc.M406920200","article-title":"Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas","volume":"279","author":"Koybasi","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.12.031_bib24","first-page":"1530","article-title":"Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma","volume":"18","author":"Yang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ymthe.2020.12.031_bib29","first-page":"9796","article-title":"Up-regulation of AKAP13 and MAGT1 on cytoplasmic membrane in progressive hepatocellular carcinoma: a novel target for prognosis","volume":"8","author":"Molee","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ymthe.2020.12.031_bib31","article-title":"EAG1 enhances hepatocellular carcinoma proliferation by modulating SKP2 and metastasis through pseudopod formation","author":"Chen","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2020.12.031_bib33","article-title":"TMEM166 inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via upregulating TP53","author":"Yang","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ymthe.2020.12.031_bib26","doi-asserted-by":"crossref","first-page":"30437","DOI":"10.1038\/srep30437","article-title":"Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysis","volume":"6","author":"Xiao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2020.12.031_bib27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/jclinpath-2011-200547","article-title":"Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma","volume":"65","author":"Zhang","year":"2012","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.ymthe.2020.12.031_bib28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2147\/OTT.S153381","article-title":"Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma","volume":"11","author":"Sheng","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/cancers12010223","article-title":"Magi1, a new potential tumor suppressor gene in estrogen receptor positive breast cancer","volume":"12","author":"Alday-Parejo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2020.12.031_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/08941939.2011.606875","article-title":"Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma","volume":"25","author":"Zhang","year":"2012","journal-title":"J.\u00a0Invest. Surg."},{"key":"10.1016\/j.ymthe.2020.12.031_bib25","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1073\/pnas.1117032109","article-title":"Induction of hepatocellular carcinoma by in\u00a0vivo gene targeting","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.12.031_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12885-015-1591-4","article-title":"Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13","volume":"15","author":"Bentin Toaldo","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ymthe.2020.12.031_bib32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1139\/bcb-2017-0062","article-title":"Kv10.1 potassium channel: from the brain to the tumors","volume":"95","author":"C\u00e1zares-Ordo\u00f1ez","year":"2017","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.ymthe.2020.12.031_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yexcr.2017.02.003","article-title":"EVA1A inhibits GBM cell proliferation by inducing autophagy and apoptosis","volume":"352","author":"Shen","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymthe.2020.12.031_bib37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/hum.2017.151","article-title":"AAVrh10 gene therapy ameliorates central and peripheral nervous system disease in canine globoid cell leukodystrophy (Krabbe Disease)","volume":"29","author":"Bradbury","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.15252\/emmm.201505850","article-title":"Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy","volume":"8","author":"Meneghini","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2020.12.031_bib39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ymthe.2018.01.009","article-title":"Long-term improvement of neurological signs and metabolic dysfunction in a mouse model of Krabbe\u2019s disease after global gene therapy","volume":"26","author":"Marshall","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ajpath.2013.10.011","article-title":"Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy","volume":"184","author":"Snook","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2020.12.031_bib41","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1093\/hmg\/dds313","article-title":"The galactocerebrosidase enzyme contributes to maintain a functional neurogenic niche during early post-natal CNS development","volume":"21","author":"Santambrogio","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.12.031_bib42","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jnr.23804","article-title":"Neuroimmune mechanisms in Krabbe\u2019s disease","volume":"94","author":"Potter","year":"2016","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ymthe.2020.12.031_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/mt.2016.17","article-title":"Genotoxicity in mice following AAV gene delivery: a safety concern for human gene therapy?","volume":"24","author":"Chandler","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2014.210","article-title":"Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates","volume":"23","author":"Meyer","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib46","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib47","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1038\/ncomms7684","article-title":"The genome-wide effects of ionizing radiation on mutation induction in the mammalian germline","volume":"6","author":"Adewoye","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2020.12.031_bib48","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2020.167","article-title":"Adeno-associated virus-induced dorsal root ganglion pathology","volume":"31","author":"Hordeaux","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib49","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3389","article-title":"Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas","volume":"47","author":"Nault","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2020.12.031_bib50","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1471-4159.1996.66031118.x","article-title":"Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe\u2019s disease","volume":"66","author":"Sakai","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2020.12.031_bib51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymthe.2005.04.019","article-title":"AAV2\/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2","volume":"12","author":"Lin","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.12.031_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0014-5793(97)00313-X","article-title":"\u2018Green mice\u2019 as a source of ubiquitous green cells","volume":"407","author":"Okabe","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2020.12.031_bib53","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajpath.2016.12.005","article-title":"Acid ceramidase deficiency in mice results in a broad range of central nervous system abnormalities","volume":"187","author":"Sikora","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2020.12.031_bib54","doi-asserted-by":"crossref","first-page":"e4235","DOI":"10.1002\/bmc.4235","article-title":"A HILIC-MS\/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum","volume":"32","author":"Sidhu","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ymthe.2020.12.031_bib55","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620307243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620307243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:45:53Z","timestamp":1778816753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620307243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1525001620307243"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.12.031","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.01.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}